ELVN
Price
$21.41
Change
-$0.34 (-1.56%)
Updated
Oct 17 closing price
Capitalization
1.27B
19 days until earnings call
Intraday Buy/Sell Signals
VYGR
Price
$4.95
Change
-$0.38 (-7.13%)
Updated
Oct 17 closing price
Capitalization
274.57M
30 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ELVN vs VYGR

Header iconELVN vs VYGR Comparison
Open Charts ELVN vs VYGRBanner chart's image
Enliven Therapeutics
Price$21.41
Change-$0.34 (-1.56%)
Volume$485.19K
Capitalization1.27B
Voyager Therapeutics
Price$4.95
Change-$0.38 (-7.13%)
Volume$494.35K
Capitalization274.57M
ELVN vs VYGR Comparison Chart in %
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELVN vs. VYGR commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELVN is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ELVN: $21.41 vs. VYGR: $4.95)
Brand notoriety: ELVN and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELVN: 98% vs. VYGR: 67%
Market capitalization -- ELVN: $1.27B vs. VYGR: $274.57M
ELVN [@Biotechnology] is valued at $1.27B. VYGR’s [@Biotechnology] market capitalization is $274.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELVN’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • ELVN’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than ELVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELVN’s TA Score shows that 6 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • ELVN’s TA Score: 6 bullish, 3 bearish.
  • VYGR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than VYGR.

Price Growth

ELVN (@Biotechnology) experienced а +2.83% price change this week, while VYGR (@Biotechnology) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ELVN is expected to report earnings on Nov 06, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELVN($1.27B) has a higher market cap than VYGR($275M). ELVN YTD gains are higher at: -4.844 vs. VYGR (-12.698). ELVN (-113.93M) and VYGR (-119.18M) have comparable annual earnings (EBITDA) . ELVN has more cash in the bank: 491M vs. VYGR (43.9M). ELVN has less debt than VYGR: ELVN (580K) vs VYGR (40.2M). VYGR has higher revenues than ELVN: VYGR (42.6M) vs ELVN (0).
ELVNVYGRELVN / VYGR
Capitalization1.27B275M461%
EBITDA-113.93M-119.18M96%
Gain YTD-4.844-12.69838%
P/E RatioN/A6.00-
Revenue042.6M-
Total Cash491M43.9M1,118%
Total Debt580K40.2M1%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELVNVYGR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
ELVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EIPAF18.34N/A
N/A
ENI S.p.A.
SNBIF16.45N/A
N/A
Sanbio Co Ltd.
NRXXY11.52N/A
N/A
NORDEX SE
VLQCF0.29N/A
N/A
Quantum Graphite Ltd.
RBCN4.26-0.01
-0.32%
Rubicon Technology, Inc.

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with NUVL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
-1.56%
NUVL - ELVN
54%
Loosely correlated
+2.32%
SYRE - ELVN
52%
Loosely correlated
+1.03%
XNCR - ELVN
52%
Loosely correlated
-1.20%
DNLI - ELVN
51%
Loosely correlated
-0.36%
NRIX - ELVN
51%
Loosely correlated
-1.89%
More